Researchers present sensor prototype that can rapidly, precisely, and cost-effectively measure molecular signals for cancer
The CRISPR/Cas technology can do more than alter genes. A research team at the University of Freiburg is using what are known as gene scissors – which scientists can use to edit genetic material – in order to better diagnose diseases such as cancer. In a study, the researchers introduce a microfluidic chip which recognizes small fragments of RNA, indicating a specific type of cancer more rapidly and precisely than the techniques available up to now. The results are recently published in the scientific journal “Advanced Materials.” They also tested the CRISPR biosensor on blood samples taken from four children who had been diagnosed with brain tumors. “Our electrochemical biosensor is five to ten times more sensitive than other applications which use CRISPR/Cas for RNA analysis,” explains Freiburg microsystems engineer Dr. Can Dincer. He is leading the research team together with biologist Prof. Dr. Wilfried Weber, of the University of Freiburg. “We’re doing pioneering work in Germany and Europe for this new application of gene scissors,” Dincer emphasizes.
Short molecules known as microRNA (miRNA) are coded in the genome, but unlike other RNA sequences, they are not translated into proteins. In some diseases, such as cancer or the neurodegenerative disease, Alzheimer’s, increased levels of miRNA can be detected in the blood. Doctors are already using miRNAs as a biomarker for certain types of cancer. Only the detection of a multitude of such signaling molecules allows an appropriate diagnosis. The researchers are now working on a version of the biosensor that recognizes up to eight different RNA markers simultaneously.
The CRISPR biosensor works as follows: A drop of serum is mixed with reaction solution and dropped onto the sensor. If it contains the target RNA, this molecule binds with a protein complex in the solution and activates the gene scissors – in a way similar to a key opening a door lock. Thus activated, the CRISPR protein cuts off, or cleaves, the reporter RNAs that are attached to signaling molecules, generating an electrical current. The cleavage results in a reduction of the current signals which can be measured electrochemically and indicates if the miRNA that is being sought is present in the sample. “What’s special about our system is that it works without the replication of miRNA, because in that case, specialized devices and chemicals would be required. That makes our system low-cost and considerably faster than other techniques or methods,” explains Dincer. He is working on new sensor technologies at the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and together with Prof. Dr. Gerald Urban at the Department of Microsystems Engineering (IMTEK).
Weber, a professor of synthetic biology at the cluster of excellence CIBSS – the Centre for Integrative Biological Signalling Studies of the University of Freiburg – emphasizes how important the interdisciplinary environment at CIBSS is for such a development: “The biologists at Freiburg work together on these technologies with their colleagues from the engineering and materials sciences. That opens new, exciting routes to solutions.” The researchers are aiming to further develop the system in about five to ten years to become the first rapid test for diseases with established microRNA markers that can be used right at the doctor’s office. “The laboratory equipment must nevertheless become easier to handle,” says Weber.
Learn more: Using Gene Scissors to Detect Diseases
The Latest Google Headlines on:
The Latest Bing News on:
- Detection of non-targeted transgenes by whole-genome resequencing for gene-doping controlon August 7, 2020 at 6:30 am
Sequencing data of transgenic cell lines will be provided upon request to the corresponding author because of gene doping control in the horseracing industry. Neuberger EWI, Simon P. Gene and cell ...
- Multiscale causal networks identify VGF as a key regulator of Alzheimer’s diseaseon August 7, 2020 at 2:30 am
These probabilistic causal models enabled detection, prioritization and replication of high ... Finally, AD discriminatory power of KDs allows one to directly assess importance to disease. We ...
- Michigan couple says they’ve trained detection dogs to sniff out coronaviruson August 6, 2020 at 7:32 pm
Lori and Jack Grigg have trained dogs to provide services like detecting bed bugs or alerting diabetics of drops in their insulin levels. In recent months, they’ve taken on a new trial -- teaching ...
- Retina-AI Health raises $5.2M for AI-powered disease-detection softwareon August 6, 2020 at 12:41 pm
A Houston-based developer of image detection software powered by artificial intelligence nabbed new growth funding.
- MDH: Sexually Transmitted Diseases Continue Upward Climb In 2019on August 5, 2020 at 11:27 am
The Minnesota Department of Health on Wednesday reported that the number of new sexually transmitted diseases (STDs) continued to rise in 2019, according to MDH's annual STD surveillance report.
- CDC warns coronavirus measures could disrupt detection of rare, paralyzing polio-like disease in childrenon August 5, 2020 at 10:20 am
Scientists say it’s possible that mask wearing, school closures and others measures designed to stop spread of the coronavirus may also hamper spread of a polio-like condition called acute flaccid ...
- RNA scientists advance early detection of Duchene muscular dystrophyon August 4, 2020 at 1:58 pm
The devastating effects of Duchene muscular dystrophy (DMD) can be mitigated if detection takes place in ... from healthy donors and donors with a disease. By combining this technique with ...
- INVEST Pitch Perfect winner spotlight: Amplified Sciences targets early pancreatic cancer detectionon August 4, 2020 at 8:48 am
Amplified Sciences emerged as the winner of the diagnostics track for the MedCity INVEST conference's Pitch Perfect contest with PanCystPro, the test it is developing to address the problems ...
- Researchers receive $2.97 million grant for testing early detection of liver canceron August 3, 2020 at 7:55 pm
Rong “HR” Tseng and Dr. Vatche Agopian of the UCLA Jonsson Comprehensive Cancer Center were awarded the grant from the National Cancer Institute.
- Advancing Early-detection Measures Seek to Curb Cancer's Progressionon August 3, 2020 at 6:52 am
"Given breast cancer's inherent tumor heterogeneity and the high prevalence of bone metastasis in advanced disease, our Guardant360 liquid biopsy can help overcome the challenges of tissue and bone ...
The Latest Google Headlines on:
The Latest Bing News on:
- Virtual Event: CRISPR’s forward marchon August 5, 2020 at 7:54 am
Join STAT as we speak with a panel of experts to share theories on how versatile CRISPR technologies may move from the lab to clinical trials.
- CRISPR Technology Global Market Report 2020-30: Covid 19 Growth and Changeon July 30, 2020 at 5:13 am
Inc. The merger is aimed at accelerating the development of the genome sensor that combines Nanosens' CRISPR-Chip technology with Cardea's graphene biosensor infrastructure and is the first DNA ...
- Researchers map mechanisms in the largest CRISPR systemon July 28, 2020 at 5:01 pm
The largest and most complex CRISPR system has been visualized by researchers in a new study. The system may have potential applications in biomedicine and biotechnology, the researchers believe.
- CRISPR Isn't Just for Gene Editing Anymoreon July 28, 2020 at 1:11 am
All this adds up to the potential of CRISPR as not just a gene-editing powerhouse, but a multifunctional tool that also works as a biosensor, a medical detective, and an invaluable instrument for ...
- Bacterial protein puts the breaks on CRISPR–Cas13 editingon July 27, 2020 at 10:43 am
Scientists have discovered that a single protein derived from Listeria seeligeri – a type of bacteria commonly found in soil – could aid in greater specificity in the CRISPR–Cas13 editing process.